While hypophosphatemia has known adverse effects, including muscle cramping, weakness, respiratory depression, rhabdomyolysis, and osteomalacia (29), the clinical implications of low FGF-23 remain unclear. The gene discussed is FGF23; the disease is hypophosphatemia.